FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087069 [Registered on: 16/05/2025] Trial Registered Prospectively
Last Modified On: 10/05/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Effectiveness of Advanced Platelet-Rich Fibrin (A-PRF) as an Adjunct to Scaling and Root Planing in Periodontitis Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Study 
Scientific Title of Study   Evaluation of Advanced Platelet-Rich Fibrin (A-PRF) as an Adjunct to Scaling and Root Planing in Periodontitis Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Study" 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anubha Singh 
Designation  Post Graduate Student 
Affiliation  AB Shetty Memorial Institute Of Dental Sciences 
Address  Dr Anubha Singh, Department Of Periodontology ,ABShetty Institute Of Medical Sciences, Mangalore

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9538898868  
Fax    
Email  anubhasingh08031997@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof (Dr) Santhosh Shenoy 
Designation  Additional professor 
Affiliation  AB Shetty Memorial Institute Of Dental Sciences 
Address  Prof(Dr) Santhosh Shenoy, Additional Professor, Department Of Periodontology, ABShetty Institute Of Medical Sciences, Mangalore

Dakshina Kannada
KARNATAKA
575022
India 
Phone  9448104417  
Fax    
Email  drsanthoshshenoy@nitte.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Anubha Singh 
Designation  Post Graduate Student 
Affiliation  AB Shetty Memorial Institute Of Dental Sciences 
Address  Dr Anubha Singh, Department Of Periodontology ,ABShetty Institute Of Medical Sciences, Mangalore


KARNATAKA
575018
India 
Phone  9538898868  
Fax    
Email  anubhasingh08031997@gmail.com  
 
Source of Monetary or Material Support  
dr Anubha Singh AB SHETTY MEMORIAL INSTITUTE OF DENTAL SCIENCES ,DERALAKATTE,MANGALORE,Karnataka,575022 
 
Primary Sponsor  
Name  Dr Anubha Singh 
Address  Dr Anubha Singh, Department Of Periodontology ,ABShetty Institute Of Medical Sciences, Deralakatte, Mangalore,Karnataka,India 575022 
Type of Sponsor  Other [self sponsored] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anubha Singh  A B SHETTY MEMORIAL INSTITUTE OF DENTAL SCIENCES   DEPARTMENT OF PERIODONTOTLOGY,A B SHETTY MEMORIAL INSTITUTE OF DENTAL SCIENCES,DERALAKATTE,MANGALORE Dakshina Kannada KARNATAKA
Dakshina Kannada
KARNATAKA 
9538898868

anubhasingh08031997@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
A B SHETTY MEMORIAL INSTITUTE OF DENTAL SCIENCES INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K051||Chronic gingivitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Advanced platelet rich fibrin (A-PRF)  10 ml of peripheral blood will be drawn from the antecubital vein of each patient into sterile non-coated plastic vacutainers without any anticoagulants. A-PRF produced by Duo Quattro with a 40-degree rotor angulation and a radius of 88mm to the minimum and 110 to the maximum at 1300 rpm for 8 min. A-PRF membranes will be created in the 10 ml test tube. After centrifugation, three different layers formed in each Tarsons 15ml graduated centrifuge tube from bottom to top as follows: red blood cell clot, platelet-rich fibrin clot and liquid plasma layer. The fibrin clot will be then held with anatomical tweezers and separated from the other two layers with surgical scissors. Afterward, It will be placed in a PRF box and pressed between two flat metal plates which will transform it into a membrane. The membrane will be cut into even pieces. A-PRF will be placed in the Test site using packing instruments after scaling and root planning. After scaling and root planning, the control sites will be treated with saline in a similar manner for the placebo effect.  
Comparator Agent  Scaling and Root planning  After screening examination random sites in split mouth are allocated as test and the contralateral site is allocated as control.Patient will undergo full mouth scaling and root planning followed by saline irrigation in both the test and control site.  
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  stage III periodontitis.
2 single rooted teeth in different quadrants.
periodontal destruction in more than 2 interproximal sites in non adjacent sites.
patient willing to attend 3 month and 6 month follow up.
 
 
ExclusionCriteria 
Details  pregnant or lactating women.
current smokers
patients with any other systemic diseases(cardiovascular disease, autoimmune disorders platelet disorders)
taking medications that affect wound healing (bisphosphonates, high-dose steroids.
history of periodontal treatment within 6 months.
history of radiotherapy or chemotherapy.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Periodontal Pocket Depth (PPD)
Clinical Attachment Loss
Visual Analogue scale (VAS)score
 
1 week, 3 months and 6 months. 
 
Secondary Outcome  
Outcome  TimePoints 
Visual Analogue scale (VAS)score  1 week. 
 
Target Sample Size   Total Sample Size="110"
Sample Size from India="110" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="1" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [anubhasingh08031997@gmail.com].

  6. For how long will this data be available start date provided 02-01-1970 and end date provided 02-01-1970?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

The periodontium consists of tissues that support the dentition, including the gingiva, periodontal ligament, and alveolar bone. Periodontal health relies on maintaining host-microbe homeostasis, which is disrupted in diabetes mellitus, leading to accelerated periodontal destruction and impaired wound healing. The initial step in periodontal disease treatment involves professional cleaning through scaling and root planing (SRP) to remove supra- and subgingival plaque and calculus, followed by evaluation. Various therapeutic approaches have been suggested to enhance SRP outcomes and minimize surgical interventions. Advanced Platelet-Rich Fibrin (A-PRF) has shown promising potential in wound healing and tissue regeneration through the sustained release of growth factors. The fibrin structure in A-PRF, characterized by thick fibers, branch points, porosity, and permeability, enhances wound stabilization. This randomized split-mouth study will evaluate the efficacy of A-PRF as an adjunct to SRP in diabetic patients, with test sites receiving A-PRF while control sites undergo SRP alone.

The study aims to compare the effectiveness of A-PRF in conjunction with SRP in Type II diabetic patients with periodontitis. The objectives include assessing the effectiveness of A-PRF combined with SRP, evaluating SRP alone, and comparing the outcomes of both treatments. Inclusion criteria include patients aged 30-60 years with Type II diabetes and diagnosed with stage III periodontitis (5-7mm probing pocket depth and attachment loss). Patients must require periodontal treatment for at least two single-rooted teeth in different quadrants and have periodontal destruction at two non-adjacent interproximal sites. Exclusion criteria include pregnancy, smoking, systemic diseases, medications affecting wound healing, recent periodontal treatment, and a history of radiotherapy or chemotherapy. The study follows a randomized split-mouth design with 50 test and 50 control teeth. The sample size is calculated as 110, considering a 10% attrition rate, with a 95% confidence level and pooled standard deviation estimates of 0.66 (Group I) and 0.54 (Group II).

The methodology includes fabricating acrylic stents, conducting blood tests, preparing A-PRF, and documenting periodontal clinical parameters such as the Gingival Index, probing pocket depth (PPD), and clinical attachment level (CAL) using a UNC-15 probe and acrylic stent for standardization. A Visual Analogue Scale (VAS) will be recorded for pain assessment. All patients will undergo full-mouth SRP, with test sites receiving subgingival A-PRF and both test and control sites covered with COE-PAK periodontal dressing. Periodontal assessments will be conducted at 1 week, 3 months, and 6 months. Data will be analyzed using SPSS version 22.0, with ANOVA and Independent ’t’ tests used for group comparisons. A p-value of <0.05 will be considered statistically significant, and Karl Pearson correlation will assess relationships between variables.

 
Close